C-reactive protein and myocardial infarction

Area of Science:

• Cardiovascular Disease Research
• Inflammation Biomarkers

Background:

• C-reactive protein (CRP) is a known predictor of cardiovascular disease.
• The differential impact of CRP on cardiovascular risk across various strata and follow-up durations requires further investigation.

Purpose of the Study:

• To evaluate the association between C-reactive protein (CRP) levels and the incidence of myocardial infarction (MI) over a 20-year follow-up period.
• To examine how this association varies based on cardiovascular risk factors and follow-up duration.

Main Methods:

• A case-control study design was employed within the Honolulu Heart Program.
• 369 myocardial infarction (MI) cases were compared with 1,348 control subjects, aged 48-70 years and initially free of disease.
• Statistical analyses were adjusted for cardiovascular risk factors.

Main Results:

• Increased C-reactive protein (CRP) levels were significantly associated with higher odds of myocardial infarction (MI) as early as 5 years post-measurement (P = 0.009).
• This association persisted over time, though effects diminished after 15 years.
• Elevated CRP showed a more pronounced adverse effect in younger men (≤55 years), non-smokers, and those without hypertension or diabetes.

Conclusions:

• In clinically healthy middle-aged men, elevated C-reactive protein (CRP) is linked to an increased risk of myocardial infarction (MI).
• Inflammation, as indicated by CRP, may play a crucial role in the early stages of atherosclerosis, potentially preceding other risk factors.
• The predictive value of CRP for MI risk is influenced by individual risk factor profiles and follow-up duration.